Your browser doesn't support javascript.
loading
A Target Engagement Assay to Assess Uptake, Potency, and Retention of Antibiotics in Living Bacteria.
Fanti, Rebeka C; Vasconcelos, Stanley N S; Catta-Preta, Carolina M C; Sullivan, Jaryd R; Riboldi, Gustavo P; Dos Reis, Caio V; Ramos, Priscila Z; Edwards, Aled M; Behr, Marcel A; Couñago, Rafael M.
Afiliación
  • Fanti RC; Centro de Química Medicinal (CQMED), Centro de Biologia Molecular e Engenharia Genética (CBMEG), Universidade Estadual de Campinas (UNICAMP), Campinas 13083-886, Brazil.
  • Vasconcelos SNS; Post-Graduate Program in Genetics and Molecular Biology (PGBM), UNICAMP, Campinas 13083-970, Brazil.
  • Catta-Preta CMC; Centro de Química Medicinal (CQMED), Centro de Biologia Molecular e Engenharia Genética (CBMEG), Universidade Estadual de Campinas (UNICAMP), Campinas 13083-886, Brazil.
  • Sullivan JR; Centro de Química Medicinal (CQMED), Centro de Biologia Molecular e Engenharia Genética (CBMEG), Universidade Estadual de Campinas (UNICAMP), Campinas 13083-886, Brazil.
  • Riboldi GP; Department of Microbiology & Immunology, McGill University, Montréal H3A 2B4, Canada.
  • Dos Reis CV; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal H4A 3J1, Canada.
  • Ramos PZ; McGill International TB Centre, Montréal H4A 3S5, Canada.
  • Edwards AM; Centro de Química Medicinal (CQMED), Centro de Biologia Molecular e Engenharia Genética (CBMEG), Universidade Estadual de Campinas (UNICAMP), Campinas 13083-886, Brazil.
  • Behr MA; Centro de Química Medicinal (CQMED), Centro de Biologia Molecular e Engenharia Genética (CBMEG), Universidade Estadual de Campinas (UNICAMP), Campinas 13083-886, Brazil.
  • Couñago RM; Centro de Química Medicinal (CQMED), Centro de Biologia Molecular e Engenharia Genética (CBMEG), Universidade Estadual de Campinas (UNICAMP), Campinas 13083-886, Brazil.
ACS Infect Dis ; 8(8): 1449-1467, 2022 08 12.
Article en En | MEDLINE | ID: mdl-35815896
ABSTRACT
New antibiotics are urgently needed to counter the emergence of antimicrobial-resistant pathogenic bacteria. A major challenge in antibiotic drug discovery is to turn potent biochemical inhibitors of essential bacterial components into effective antimicrobials. This difficulty is underpinned by a lack of methods to investigate the physicochemical properties needed for candidate antibiotics to permeate the bacterial cell envelope and avoid clearance by the action of bacterial efflux pumps. To address these issues, here we used a target engagement assay to measure the equilibrium and kinetic binding parameters of antibiotics targeting dihydrofolate reductase (DHFR) in live bacteria. We also used this assay to identify novel DHFR ligands having antimicrobial activity. We validated this approach using the Gram-negative bacteria Escherichia coli and the emerging human pathogen Mycobacterium abscessus. We expect the use of target engagement assays in bacteria to expedite the discovery and progression of novel, cell-permeable antibiotics with on-target activity.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antiinfecciosos / Antibacterianos Límite: Humans Idioma: En Revista: ACS Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antiinfecciosos / Antibacterianos Límite: Humans Idioma: En Revista: ACS Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Brasil